# Johnson & Johnson (JNJ) — Q3-2022 Earnings Results

**Report date:** 2022-10-18 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2022

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.55 | N/A | +2.25% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's ability to adapt to market conditions. They emphasized a focus on innovation and operational efficiency.

**Key quotes:**

> We are focused on delivering strong results despite market challenges.

> Our commitment to innovation remains a priority as we navigate the current landscape.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson was able to exceed EPS expectations, indicating some resilience in their operations. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, which may reflect mixed investor sentiment following the report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2022_